Citius Pharmaceuticals Inc - Warrants(02/08/2022)
CTXRW
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.54M
Close$
Share Statistics
| Market cap | $5.54 Million |
|---|---|
| Enterprise Value | $1.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.38 |
| Beta | -2.77 |
| Outstanding Shares | 22,376,427 |
Return
| Return on Equity | -88.16% |
|---|---|
| Return on Assets | -40.93% |
| Return on Invested Capital | -73.84% |
Valuation & Multiples
| P/E Ratio | -0.19 |
|---|---|
| PEG | -0.13 |
| Price to Sales | - |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | -0.03 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Citius Pharmaceuticals Inc
10 employees
CEO: Myron Holubiak